Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
MTNB — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.14

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.26

Target Price

30

Analyst Recom

2

Performance Q

-56.12

Upside

-9,478.6%

Beta

1.73

Ticker: MTNB



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13MTNB0.5N/AN/A0
2026-07-14MTNB0.355N/AN/A0
2026-07-15MTNB0.341N/AN/A0
2026-07-16MTNB0.3487N/AN/A0
2026-07-17MTNB0.34N/AN/A0
2026-07-20MTNB0.3091N/AN/A0
2026-07-21MTNB0.2836N/AN/A0
2026-07-22MTNB0.2609N/AN/A0
2026-07-23MTNB0.2488N/AN/A0
2026-07-24MTNB0.242N/AN/A0
2026-07-27MTNB0.3422N/AN/A0
2026-07-28MTNB0.2952N/AN/A0
2026-07-29MTNB0.2897N/AN/A0
2026-07-30MTNB0.3197N/AN/A0
2026-07-31MTNB0.2908N/AN/A0
2026-08-03MTNB0.3029N/AN/A0
2026-08-04MTNB0.2843N/AN/A0
2026-08-05MTNB0.2735N/AN/A0
2026-08-07MTNB0.2586N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13MTNB0.48- - -
2026-07-14MTNB0.35- - -
2026-07-15MTNB0.34- - -
2026-07-16MTNB0.36- - -
2026-07-17MTNB0.34- - -
2026-07-20MTNB0.32- - -
2026-07-21MTNB0.29- - -
2026-07-22MTNB0.26- - -
2026-07-23MTNB0.25- - -
2026-07-24MTNB0.24- - -
2026-07-27MTNB0.34- - -
2026-07-28MTNB0.30- - -
2026-07-29MTNB0.29- - -
2026-07-30MTNB0.32- - -
2026-07-31MTNB0.29- - -
2026-08-03MTNB0.31- - -
2026-08-04MTNB0.31- - -
2026-08-05MTNB0.27- - -
2026-08-06MTNB0.26- - -
2026-08-07MTNB0.26- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13MTNB0.00-4.500.12
2026-07-14MTNB0.00-4.500.12
2026-07-15MTNB0.00-4.500.12
2026-07-16MTNB0.00-4.500.12
2026-07-17MTNB0.00-4.500.12
2026-07-20MTNB0.00-2.160.05
2026-07-21MTNB0.00-2.160.07
2026-07-22MTNB0.00-2.160.07
2026-07-23MTNB0.00-2.160.07
2026-07-24MTNB0.00-2.160.07
2026-07-27MTNB0.00-2.164.14
2026-07-28MTNB0.00-2.164.14
2026-07-29MTNB0.00-2.164.14
2026-07-30MTNB0.00-2.164.14
2026-07-31MTNB0.00-2.164.14
2026-08-03MTNB0.00-2.154.14
2026-08-04MTNB0.00-2.154.14
2026-08-05MTNB0.00-2.154.14
2026-08-06MTNB0.00-2.154.14
2026-08-07MTNB0.00-2.154.14
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.78

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-2.15

Beta

1.73

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

3

Growth Score

Sentiment Score

50

Actual DrawDown %

99.7

Max Drawdown 5-Year %

-99.7

Target Price

30

P/E

Forward P/E

PEG

P/S

P/B

0.6

P/Free Cash Flow

EPS

-2.02

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.22

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ MTNB Healthcare
$0.28
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
12/20
TP/AR
1/10
Options
0/10
RSI
36.4
Range 1M
4.9%
Sup Dist
8.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
6 /100
WEAK
Momentum
1/25
Growth
5/30
Estimates
0/20
Inst/Vol
0/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
1.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +10614.3% upside
Quality
2/30
Valuation
16/30
Growth
2/25
Stability
4/10
LT Trend
2/5
Upside
+10614.3%
Quality
3
Click a card to see score breakdown Full Analysis →
MTNB — P/E HistoricalBiotechnology
Matinas Biopharma Holdings, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 2
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
MTNB

Latest News

—
Caricamento notizie per MTNB…
stock quote shares MTNB – Matinas Biopharma Holdings Inc Stock Price stock today
news today MTNB – Matinas Biopharma Holdings Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MTNB – Matinas Biopharma Holdings Inc yahoo finance google finance
stock history MTNB – Matinas Biopharma Holdings Inc invest stock market
stock prices MTNB premarket after hours
ticker MTNB fair value insiders trading